Precigen (PGEN) Change in Accured Expenses (2012 - 2026)

Precigen's (PGEN) quarterly Change in Accured Expenses came in at -$2.3 million in Q1 2026, down 288.7% year-on-year from $1.2 million in Q1 2025, and down 977.22% on a QoQ basis from $259000.0 in Q4 2025.

Precigen (PGEN) Change in Accured Expenses (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Change in Accured Expenses data on file, last reported at -$2.3 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 288.7% year-over-year to -$2.3 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 24.18% decrease from a year earlier, with the FY2025 full-year figure at $6.9 million, up 118.41% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$2.3 million, down from $259000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for PGEN reached as high as $5.4 million in Q3 2023 and fell as low as -$2.8 million in Q4 2023.
  • Historically, Change in Accured Expenses has averaged $412176.5 across 5 years, with a median of -$126000.0 in 2024.
  • Across the five-year window, Change in Accured Expenses sank 366.01% in 2022 and soared 1214.69% in 2024, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$939000.0 in 2022, then slumped by 202.24% to -$2.8 million in 2023, then soared by 163.67% to $1.8 million in 2024, then slumped by 85.67% to $259000.0 in 2025, then sank by 977.22% to -$2.3 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$2.3 million in Q1 2026, $259000.0 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn - 1.13 Mn
2 Nanobiotix 1,880.51 Bn 1,880.45 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 931,000.00
4 BeOne Medicines 467.94 Bn 463.15 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.63 Bn 115.38 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.30 Bn 61.54 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.81 Bn 62.81 Bn - -
8 Argenx Se 55.78 Bn 50.59 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn -176.03 Mn
10 Precigen 2.00 Bn 2.00 Bn 20.69 Mn -2.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.27 Mn
Mar 31, 2026 -2.27 Mn
Dec 31, 2025 259,000.00
Dec 31, 2025 259,000.00
Sep 30, 2025 1.23 Mn
Sep 30, 2025 1.23 Mn
Jun 30, 2025 4.17 Mn
Jun 30, 2025 4.17 Mn
Mar 31, 2025 1.20 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 1.81 Mn
Dec 31, 2024 1.81 Mn
Sep 30, 2024 -130,000.00
Sep 30, 2024 -130,000.00
Jun 30, 2024 1.59 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 -126,000.00
Mar 31, 2024 -126,000.00
Dec 31, 2023 -2.84 Mn
Dec 31, 2023 -2.84 Mn